Skip to main content
Medic Debate
- The Antidote to Medical Misinformation and Propaganda!
Languages
Dansk
Nederlands
English
Français
Deutsch
Italiano
Español
Kiswahili
Svenska
Search form
Search
Main menu
Home
Search
About us
Books
Category Search
Log In
Recent posts
Treatment Protocols
You are here
Home
Docetaxel
Items per page
5
10
20
40
60
100
Title
Average Rating
Phase II study of docetaxel-prednisone (DP) in combination with metronomic cyclophosphamide (CTX) and celecoxib (C) ......
95.00%
Metronomic Schedule of Paclitaxel Is Effective in Hormone Receptor–Positive and Hormone Receptor–Negative Breast Cancer
80.00%
Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen
80.00%
Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer.
80.00%
The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline
70.00%
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer.
70.00%
Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer.
70.00%
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-indep..
70.00%
Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis.
60.00%
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer.
50.00%
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic
40.00%